Related by context. All words. (Click for frequent words.) 68 HbA 1c levels 68 baseline HbA1c 67 -#.# log# 66 baseline A1C 66 HbA1C levels 66 lopinavir r arm 65 Operative mortality 65 log# copies mL 65 mmol l 65 CI #.#-#.# [001] 64 Hb A1C 64 hemoglobin A1c HbA1c 64 MMSE scores 64 lumbar spine BMD 64 microbiological eradication 64 Platelet counts 64 HOMA IR 63 odds ratios ORs 63 % Confidence Interval 63 p = .# [001] 63 mean baseline HbA1c 63 statistical significance p 63 mmHg p = 63 CI #.#-#.# [002] 63 HBeAg negative patients 63 mmHg diastolic 63 PREZISTA r arm 63 DAS# CRP 62 oxycodone CR 62 TAXUS p value 62 CI -#.# 62 % CI #.#-#.# [007] 62 Ishak fibrosis score 62 definite stent thrombosis 62 -#.# mg dL [002] 62 % CI #.#-#.# [003] 62 glycated hemoglobin HbA1c 62 baseline serum creatinine 62 nonsignificant difference 62 hip BMD 62 receiving Vectibix monotherapy 62 Adjusted EBITDAR margin 62 log# IU mL 61 arterial thromboembolic events 61 % MID-EAST/AFRICA 61 low dose Iluvien 61 EDSS score 61 PASI scores 61 pooled comparator 61 GSPF slid 61 p = NS 61 confidence interval #.#-#.# 61 SUVmax 61 HbA1c levels 61 % CI #.#-#.# [008] 61 #.#/#.# mmHg [001] 61 receiving ISENTRESS 61 Uptrend Continuation 61 rectal tenesmus 61 QTcF 61 8 Cyl 61 Crohn Disease Activity 61 tapentadol ER 61 achieved ACR# 60 hemoglobin A1c levels 60 mcg linaclotide 60 TEAEs 60 nondiabetic patients 60 MADRS score 60 -#.# mg dL [001] 60 Nasdaq Composite COMP #.# 60 multivariable adjusted 60 experienced virologic failure 60 BPH Symptom Score 60 NIH CPSI 60 preintervention 60 from#.# [002] 60 -#.# log# copies mL 60 NNT = 60 4mg/kg 60 microbiologically evaluable 60 mcg QD 60 lowest tertile 60 generalized edema 60 echocardiographic parameters 60 DAS# [002] 60 mg BID dose 60 Index CDAI 60 CDAI score 60 pmol liter 60 corticosteroid dose 60 EGYPTIAN POUND 60 mL/min/#.# m 2 60 Refinery utilization rebounded 60 MMSE score 60 DJI #.# 60 P ≤ 60 glomerular filtration rate 59 binary restenosis 59 confirmed CCyR 59 p = ns 59 #.#mmol L [001] 59 IRLS score 59 HbA 1c 59 dapagliflozin plus 59 annualized relapse 59 mmol L. 59 advanced adenoma 59 BMS p = 59 inhospital mortality 59 albumin excretion rate 59 estimated GFR 59 FHLB borrowings decreased 59 confidence intervals CIs 59 mg Androxal 59 IBDQ 59 folic acid takers 59 DLQI 59 HbA1C 59 titrated glipizide plus 59 ARCOXIA 59 Projections ranged 59 mg Lucentis 59 p = .# [002] 59 mcg albinterferon alfa 2b 59 ALT elevation 59 tipranavir r 59 FluCAM arm 59 segment binary restenosis 59 poor metabolizers 59 % CI #.#-#.# [006] 59 XIENCE V PROMUS Stent 59 mL/min/#.# m2 59 KRAS mutations occur 59 heFH 59 mIU ml 59 postintervention 59 REYATAZ r arm 59 Hong Kongs Hang Seng 58 Baseline characteristics 58 mg kg Hematide 58 plus aztreonam 58 Median PFS 58 oral allopurinol 58 titrated glipizide 58 creatinine ratio 58 ACR# ACR# 58 comparator arm 58 AUA Symptom Score 58 ARB telmisartan 58 glycosylated hemoglobin HbA1c 58 ADCS CGIC 58 glycated hemoglobin levels 58 morphometric vertebral fractures 58 logMAR 58 glulisine 58 nadroparin 58 fullyear outturn represents 58 leukocyte count 58 pulmonary capillary wedge 58 pg ml 58 Score DAS# 58 nonobese 58 Montgomery Asberg Depression 58 methotrexate monotherapy 58 Hb A1c 58 #.#mg/dL 58 atheroma volume 58 certolizumab 58 undetectable HBV DNA 58 Hazard Ratio = 58 serum creatinine levels 58 Kaplan Meier analysis 58 highest tertile 58 sd = 58 EDSS scores 58 μg dL 58 P = .# 58 -#.# USD JPY [002] 58 Cardiac Surgery Systems 58 μg kg 58 ± SD 58 Nonaccrual loans totaled 58 alanine aminotransferase 58 pT3 58 BSE SMALLCAP index 58 hours postdose 58 mso footer margin 58 HAQ DI 58 p ≤ 58 elevated LDH 58 femoral neck BMD 57 urine albumin 57 PDP MLR 57 HbA 1C 57 Viread Emtriva SUSTIVA 57 Folfox 57 mL sec 57 Rating Scale MADRS 57 Skin sterol 57 adjunctive placebo 57 linaclotide treated 57 lamivudine monotherapy 57 fin div 57 Scale cognitive subscale 57 Nonperforming loans totaled 57 6 Cyl 57 log# 57 g dl 57 Xalatan R 57 complete cytogenetic response 57 mEq L 57 NHANES #-# 57 PANSS total 57 Scale EDSS score 57 overyear 57 diameter stenosis 57 CVD mortality 57 placebo dexamethasone 57 FOLFIRI alone 57 fasting serum 57 unplanned readmissions 57 budesonide pMDI 57 Fasting plasma glucose 57 serologically active patients 57 prioryear 57 UPDRS motor 57 mm Hg systolic 57 Expanded Disability Status 57 -#.# mmol L 57 PREZISTA ritonavir 57 μg L 57 stent thromboses 57 Hemoglobin A1c 57 underwent surgical resection 57 plasma homocysteine 57 median survivals 57 baseline FEV 57 IIIa inhibitors 57 IOP lowering 57 Triglyceride levels 57 mean ± SEM 57 perioperative mortality 57 TOTAL REV 57 deep venous thromboses 57 % CI #.#-#.# [001] 57 μmol l 57 calculated creatinine clearance 57 0.l 57 interquartile range 57 MIC# [001] 57 X ULN 57 clinically evaluable patients 57 SOXX gained 57 n Cooling Degree 57 Fasting blood glucose 57 lipid lowering agents 57 recurrent VTE 57 FDA defined valvulopathy 57 ug ml 57 gm dl 57 Scale EDSS 57 -#.# ± [002] 57 Confidence Interval 57 mg Proellex 57 prednisone prednisolone plus 57 Technical Downtrend Continuation 57 undetectable viral 57 % CI #.#-#.# [005] 57 ug kg 57 HDRS 57 Stent thrombosis 57 8mg/kg 57 PSA nadir 56 cm flux 56 CIMZIA ™ 56 #-#,# mg 56 NYHA functional class 56 sham injections 56 microalbumin test 56 placebo p = 56 NIHSS 56 rectal tenesmus #.# 56 Complication rates 56 Noninterest expense totaled 56 BSIs 56 PCWP 56 biopsy Gleason 56 CABG p = 56 Repliform R revenues 56 diastolic blood pressures 56 laboratory abnormalities 56 Hazard Ratio HR 56 SGRQ 56 fasting plasma glucose FPG 56 Prepaid churn 56 PSADT 56 achieved CCyR 56 & s2 = 56 Strayer Education NASDAQ STRA 56 mCi kg 56 alanine aminotransferase ALT 56 advanced adenomas 56 treat NNT 56 x ULN 56 plus dexamethasone 56 TPV r 56 noncardiovascular mortality 56 Nonresidential structures 56 ACR# response 56 ADCS ADL 56 relapsed MM 56 glipizide plus 56 elevated ALT 56 MARKET TALK Saudi 56 nicardipine 56 Index RMPI 56 postoperative mortality 56 mcg kg REBETOL 56 sUA 56 confidence interval CI 56 regression coefficient 56 SYKES Enterprises NASDAQ SYKE 56 tirofiban 56 ARCALYST ® 56 Alzheimer Disease Assessment 56 ADAS cog 56 hypoglycemic events 56 ß = 56 achieved statistical significance 56 Kaplan Meier estimates 56 adiponectin concentrations 56 microg 56 % CI #.#-#.# [004] 56 fasting insulin 56 Ryan Schnitz Buell 56 TRXFLDAXPU 56 Noninterest expense decreased 56 severe exacerbations 56 CHADS2 56 BMI z 56 aldosterone antagonist 56 Adjusted Ebitda 56 mTSS 56 REMICADE monotherapy 56 broader DJStoxx 56 Brief Psychiatric 56 FOLFOX4 56 YY =Anders Ostergaard 56 Exacta £ 56 NHANES III 56 HbA1c 56 Stent p = 56 infliximab monotherapy 56 attain statistical significance 56 highest quintile 56 XIENCE V vs. 56 and#.# [001] 56 apnea hypopnea index 56 thyrotropin levels 56 bivalirudin monotherapy 56 ACTEMRA TM 56 #mmHg [001] 56 p = #.# [003] 56 mU L 56 -#.# CBOT soy [002] 56 NAMCS 56 nmol L. 56 sirolimus stent 56 oral hypoglycemic agent 55 BENCHMRK 55 median PFS 55 #mg/day [001] 55 underwent CABG 55 receiving golimumab 55 #.#/#.# mm Hg [001] 55 μg d 55 Inventories subtracted 55 TSE# closed 55 mIU L 55 severe periodontitis 55 FTE staffing 55 salmeterol fluticasone propionate 55 Key secondary endpoints 55 Lantus ® 55 PERMP 55 tobramycin inhalation solution 55 nmol l 55 statistically significant p = 55 plasma HCV RNA 55 ratio ICER 55 μmol L 55 Engerix B 55 ug mL 55 Y BOCS 55 PRADAXA #mg 55 cEVR 55 CCyR 55 Loss severities 55 CYPHER Stent 55 clodronate 55 sternal wound infections 55 Capacity FVC 55 neutrophil counts 55 estimated glomerular filtration 55 Sequential Avg 55 LUMIGAN ® 55 serum potassium 55 steroid dexamethasone 55 mU liter 55 shorter telomere length 55 oral antidiabetic medication 55 IXIC gained 55 mg TID 55 GERD symptom 55 CIN3 55 Rating Scale BPRS 55 SIC Classification 55 leukopenia 55 pCR 55 serum estradiol 55 Health Assessment Questionnaire 55 microgram kg 55 Case persistency 55 intima media thickness 55 cisplatin vinorelbine 55 enamel defects 55 Medcath NASDAQ MDTH 55 revascularizations 55 albumin excretion 55 Insulin sensitivity 55 Ocular Surface Disease 55 Viread Emtriva Sustiva 55 specific antigen PSA 55 kg m² 55 #.#ng/ml 55 rimonabant #mg 55 TELECOMMUNICATION SERVICES 55 TRXFLDPIPU 55 Gary Scelzi Dodge Stratus 55 #.#-#.# [011] 55 mmHg systolic 55 mg p = 55 ejection fractions 55 YMRS 55 STOXX#E shed 55 mITT 55 CrCl 55 AUA BPH Symptom Score 55 abdominal pain abdominal discomfort 55 A1c levels 55 CFVR 55 Euler Hermes +#.# 55 pretest probability 55 Geographic Segmentation 55 response CCyR 55 biochemical relapse 55 #.# ASIA ADRS [002] 55 #.# ASIA ADRS [001] 55 systolic blood pressures 55 #.#mmHg 55 MCyR 55 preoperative PSA 55 moderately emetogenic 55 C diff infections 55 ANCOVA 55 Del Worsham Solara 55 Cu Equivalent 55 grams monounsaturated 55 CIN2 + 55 prospectively stratified 55 Currency translation negatively impacted 55 mm Hg diastolic 55 Lucentis monotherapy 55 mcg BID 55 prespecified secondary 55 resected pancreatic cancer 55 #.#-#.# [002] 55 IELT 55 mcg mL 55 Cystatin C 55 MSCI NYSE MXB 55 Pharmacokinetic parameters 55 Soriatane R acitretin capsules 55 TOPX gained 55 dalteparin 55 mso header 55 Secondary efficacy endpoints 55 Angelle Savoie Suzuki 55 receiving prophylactic anticoagulation 55 moderate renal impairment 55 sUA levels 55 unresectable HCC 55 Normal Heating Degree 55 HER2 expression 55 adefovir treated 55 Postoperative complications 55 sensitivity specificity 54 Whit Bazemore Dodge Stratus 54 eGFR 54 mmol kg 54 MELD scores 54 CANCIDAS 54 Housing Starts Plunge 54 Montgomery Åsberg Depression 54 anemia hemoglobin 54 atorvastatin #mg 54 from#.# [001] 54 Y gm 54 pmol L 54 uM 54 mainline PRASM 54 NATRECOR R 54 MACCE 54 CIMZIA TM certolizumab pegol 54 Timed Walk 54 endoscopic remission 54 OSE adjusted 54 glycated hemoglobin 54 log# reduction 54 stent stenosis 54 Nonperforming loans decreased 54 Hazard Ratio 54 hypophosphatemia 54 lymphocytosis 54 ADAS Cog 54 A1C levels 54 Ultane Sevorane 54 HBeAg seroconversion 54 Knightsbridge Tankers NASDAQ VLCCF 54 hydroxyvitamin D levels 54 UMich consumer sentiment 54 r2 = 54 BBB Baa BB 54 hemoglobin A1C 54 ug dose 54 nmol liter 54 sustained virological response 54 DAS# remission 54 foveal thickness 54 placebo fluoxetine 54 DAS# scores 54 mcg kg min 54 Jeff Arend Impala 54 hepatorenal syndrome 54 #Gy 54 salivary flow 54 MLP Affiliate 54 statewide unadjusted jobless 54 LV dysfunction 54 Surfactant gross 54 was#.# 54 nanograms milliliter 54 Pred Forte 54 mmol L 54 STOXX#E gained 54 intracerebral hemorrhages 54 Visual Analogue Scale VAS 54 IXIC climbed 54 angiographic outcomes 54 lispro 54 tertile 54 CROCS NASDAQ CROX 54 allele frequencies 54 primary patency 54 % TOTAL AVAIL 54 Spherion Employee Confidence Index 54 clinically evaluable 54 mcg Albuferon 54 Primary endpoints 54 baseline Hb 54 del 5q MDS 54 serum magnesium 54 Homocysteine levels 54 HBV infections 54 lumbar spine bone 54 Unified Parkinson Disease 54 urinary albumin 54 Lupuzor ™ 54 ADHD RS 54 SXDP 54 triglyceride concentration 54 NIHSS score 54 Pearson correlation coefficient 54 Available Seat Kilometres ASKs 54 serum urate 54 apolipoprotein B 54 Apidra ® 54 IGPA edged 54 amoxicillin clavulanate 54 ACR Pedi 54 -#.# p = 54 AXFJ 54 plus GP IIb 54 micrograms mL 54 arterial thromboembolism 54 Greg Stanfield GXP 54 neuropathy sensory 54 imipenem 54 APTIVUS r 54 plus methotrexate 54 intraobserver 54 Hospitalizations 54 identifying beta coefficient 54 ® fluocinonide Cream 54 serum sodium levels 54 nonobstructive CAD 54 recurrent venous thromboembolism 54 ISM nonmanufacturing index 54 Wireline adjusted EBITDA 54 Nonoperating expense 54 T2 lesion volume 54 Noninterest Expense Noninterest expense 54 nondepressed 54 unfractionated heparin UFH 54 glycosylated hemoglobin 54 dizziness nausea diarrhea 54 fluticasone salmeterol 54 highly emetogenic 54 pg mL 54 iPTH 54 μg mL 54 EURIDIS 54 pulsatility index 54 CR nPR 54 HAM D# scores 54 OS = ISD/#/#/# 54 postoperative complication 54 overt nephropathy 54 p = #.# [002] 54 clinically meaningful improvement 54 Forecasts ranged 54 preoperatively 54 mg kg dose 54 PANSS 54 Median progression 54 Skilled vacancies 54 microalbumin 54 Viropharma NASDAQ VPHM 54 refractory ischemia 54 graft occlusion 54 Passenger Load Factor 54 multivariable analysis 54 Teck Resources TCK.B.TO 54 Annualized ROE 54 mmol liter 54 pg g 54 TLUS 54 FluCAM 54 TRXFLDGLPU 54 lipid lowering medications 54 Max Naylor Stratus 54 Co. NYSE HNZ 54 Valueclick NASDAQ VCLK 54 bronchoalveolar lavage 54 Churn Rate 54 placebo p 54 creatinine clearance 54 JGB yield edged 54 USD CHF shedding 54 Del Worsham Monte Carlo 54 #.#/#.# mm Hg [003] 54 inhospital 54 suboptimal adherence 54 IELEC.T 54 CNS LS 54 Psoriasis Area 54 Index CDAI score 54 univariate 53 adjunctive ABILIFY 53 atazanavir ritonavir 53 SmartGrowth Deposits 53 nonfatal MI 53 receiving PEGINTRON 53 retrospective cohort 53 Diluted HEPS 53 receiving VICTRELIS 53 LOVENOX 53 concomitant medications 53 metabolite concentrations 53 prevalences 53 sustained virologic response 53 Omnicell NASDAQ OMCL 53 acute myocardial infarctions 53 Charlson comorbidity index 53 DRDGold Ltd. DROOY 53 Phil Burkart Monte Carlo 53 coronary stenosis 53 HUL +#.# 53 serum clusterin levels 53 prospectively defined 53 AVAILABLE SEAT KM 53 intact parathyroid hormone 53 benazepril 53 Indonesia JSX Composite 53 events MACE 53 interobserver reliability 53 Wireline EBITDA 53 ANOVA 53 ipsilateral stroke 53 Drug eluting stent 53 homocysteine concentrations 53 Eric Medlen Mustang 53 Taxus Stent 53 diastolic pressures 53 Technical Uptrend Reversal 53 LV ejection fraction 53 tipranavir ritonavir 53 Gary Densham Monte Carlo 53 elevated triglyceride levels 53 CI = 53 nocturnal awakenings 53 cholesterol triglyceride 53 mineral density BMD 53 PaO 2 53 g dL 53 kcal d 53 futures SPc1 rose 53 #mg BID [001] 53 baseline LDH 53 Matt Guidera Buell 53 platelet reactivity 53 intraclass correlation coefficient 53 5-FU/LV 53 #.# [001] 53 Santarus NASDAQ SNTS 53 TTM Technologies NASDAQ TTMI 53 dose Iluvien 53 Financials firmed 53 MDRD equation 53 Incr 53 peripheral sensory neuropathy 53 Ejection Fraction 53 CHD mortality 53 MCXCOMDEX trades 53 serum phosphate 53 Cronbach alpha 53 sputum eosinophils 53 evaluable subjects 53 rhinoconjunctivitis 53 lymphocyte count 53 LANTUS R 53 latest AAII Sentiment 53 ETDRS 53 FOLFOX4 alone 53 acarbose 53 Rates Euribor 53 oxycodone IR 53 nonvertebral fractures 53 cytogenetic response 53 HUL -#.# 53 hemoglobin A1C HbA1C 53 OshKosh wholesale 53 fosamprenavir 53 IRLS 53 detectable BPA 53 increaseof 53 rosuvastatin #mg 53 Patterson NASDAQ PDCO 53 cerebrovascular events 53 Kenny Koretsky Cobalt 53 -#.# DOW JONES 53 CDAI 53 Occupancy Percentage 53 #R #R #R [002] 53 #.#mmol L [002] 53 noninterest expense decreased 53 URTI 53 multivariate analyzes 53 WOMAC pain 53 GG genotype 53 aged ≥ 53 Biaxin clarithromycin 53 median CD4 53 Leverage ratios 53 flow mediated dilation 53 hepatic enzymes 53 Zometa hazard 53 Horsehead NASDAQ ZINC 53 SWEDISH KRONA 53 irbesartan 53 MS DRGs 53 stent binary restenosis 53 systolic BP 53 Real disposable incomes 53 serum IGF 53 serum HBV DNA 53 Align Technology NASDAQ ALGN 53 S. aureus isolates 53 mg QD 53 chlorambucil 53 spirometric 53 hemoglobin concentration 53 SGPT 53 serum lipid levels 53 SHARE ACTION Down 53 squamous histology 53 nonpetroleum import prices 53 Replikin Count 53 quetiapine XR 53 PROCTOCORT ® Suppository Hydrocortisone 53 mg ustekinumab 53 plus OBT 53 arterial oxygen saturation 53 CFNAI 53 ertapenem 53 incontinence episodes 53 serum aminotransferase levels 53 MILLION SHARES 53 Ron Capps Charger 53 kappa = 53 rFSH 53 postdose 53 Jeg Coughlin Cobalt 53 statin monotherapy 53 Endologix NASDAQ ELGX 53 Myalgia 53 Brief Pain 53 placebo PBO 53 Kenny Koretsky Stratus 53 Arch Intern Med 53 Tony Pedregon Impala 53 dosing cohort 53 #OHD 53 mg/# hours 53 VFQ 53 Forced Vital 53 Inflation quickened 53 TEUR -# 53 lifetime abstainers 53 μg dose 53 XIENCE V demonstrated 53 TTM gross 53 carotid artery thickness 53 achieved sustained virological 53 lowest quintile 53 nondiabetic 53 aspartate aminotransferase AST 53 hemoglobin concentrations 53 splenectomized patients 53 IFN alfa 53 HCV antibody 53 NPH insulin 53 elevated LDL cholesterol 53 thrombosis embolism 53 NBV margin 53 American Plc AAUK 53 nonsignificant 53 ± SEM 53 octreotide LAR 53 % mlink 53 μg doses 53 symptomatic intracranial hemorrhage 53 GSPIC 53 lactate dehydrogenase 53 Preoperatively 53 IQR 53 mineral density 53 2 #/#-year CDs 53 troponin T 53 mg dL 53 baseline FEV1 53 TIMP 1 53 IPSS 53 Sales excluding autos 53 Gary Scelzi Charger 53 μg g 53 symptomatic GERD 53 fructosamine 53 intramuscular dose 53 JPY9 53 hsCRP levels 53 NASS butter 53 severe asthma exacerbations 53 de aths 53 NUMBER OF TRADERS 53 conjunctival hyperemia 53 spine BMD 52 seropositivity 52 total cholesterol triglycerides 52 CI #.#-#.# p = 52 non squamous histology 52 Fully diluted EPS 52 Tony Pedregon Monte Carlo 52 nonvertebral fracture 52 fasting plasma 52 Omnova Solutions NYSE OMN 52 Active Trader DARTs 52 LIBOR LIBOR 52 colorectal adenoma 52 nonsevere disability 52 multivariate Cox 52 cGy 52 myocardial viability 52 Angiomax monotherapy 52 ISECU.T 52 Hemoglobin A1c HbA1c 52 BMI percentiles 52 Multivariate analysis revealed 52 aminotransferase elevations greater 52 RLAI 52 Nonperforming assets totaled 52 serum CRP 52 mg qd 52 nonexposed 52 Nonfarm productivity 52 pyrexia mucositis sepsis febrile 52 Cerus NASDAQ CERS 52 oral antidiabetes 52 LVEF 52 histologic subtype 52 serum lipid 52 cerebral oxygenation 52 Homes Sold tbr 52 TAXUS Express Stent 52 PRADAXA 52 stage IIIb IV 52 Kaplan Meier 52 posttreatment 52 mg XP# 52 lopinavir r 52 mm ³ 52 benchmark IPCA inflation 52 diastolic BP 52 Univariate analysis 52 serum sodium concentration 52 Cystic Fibrosis Questionnaire Revised 52 BKEUR 52 severe NCI CTC 52 up#.# [001] 52 TOPX inched 52 carotid artery narrowing 52 Impala Platinum Holdings IMPUY 52 angiographic restenosis 52 postoperative morbidity 52 oral diclofenac 52 LE Tonglet Suzuki 52 aOR 52 PMPM basis 52 liver histology 52 mg/m2 dose 52 retrospective observational study 52 dose dabigatran 52 UPDRS 52 hemodynamic measurements 52 DISCLOSURE UNDER RULES 52 extrapyramidal symptoms 52 GSPINSC 52 QM MSP 52 IIIa inhibitor 52 RECIST Response Evaluation Criteria 52 tolterodine ER 52 mcg dL 52 French CAC# 52 Discounting civil servants 52 Fasting glucose levels 52 tertiles 52 T2 lesions 52 nasal symptom 52 Adjusted EBITDA1 52 serum urate levels 52 Free Survival PFS 52 VirnetX Holding AMEX VHC 52 transaminase levels 52 Selling Expenses 52 TMC# r 52 TEB adjustment 52 active comparator 52 Billable headcount 52 InterOil AMEX IOC 52 theprior 52 LPV r 52 SEISMIC Trial 52 cytogenic 52 Sees FY# revs 52 quarter offiscal 52 serum phosphate levels 52 Ctrip.com International NASDAQ CTRP 52 TOPIX shed 52 mg + GLY 52 #mg dose [002] 52 atypical ductal hyperplasia 52 ASD prevalence 52 oxygen desaturation 52 Mortgage loan fundings 52 SX3P 52 Chicagoland PMSA 52 virological response 52 NCT# ClinicalTrials.gov 52 percentto 52 limiting generalizability 52 HORIZONS AMI trial 52 pain subscale 52 SAVVIS NASDAQ SVVS 52 Interrater reliability 52 Response Evaluation Criteria 52 HedgersEdge packer margin 52 FHLB advances decreased 52 Primary Endpoint